Chris Hani Baragwanath Hospital is a hospital in Johannesburg, South Africa, it is the largest hospital in Africa and third largest hospital in the world. It has 6,760 staff members, 3,400 beds and occupies 70 ha. The hospital is located in the Soweto area south of Johannesburg.

There are 3 400 beds in Chris Hani Baragwanath Hospital.

During the past decade, Chris Hani Baragwanath Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chris Hani Baragwanath Hospital" #1 sponsor was "University of Witwatersrand, South Africa" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Chris Hani Baragwanath Academic Hospital" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chris Hani Baragwanath Hospital" #1 collaborator was "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Actoverco" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Chris Hani Baragwanath Hospital" are "HIV Infections" (6 trials), "Ulcerative Colitis" (3 trials), "Meningitis" (2 trials), "Pneumonia" (2 trials) and "Tuberculosis" (2 trials). Many other conditions were trialed in "Chris Hani Baragwanath Hospital" in a lesser frequency.

Most popular intervention types in "Chris Hani Baragwanath Hospital" are "Drug" (27 trials), "Biological" (10 trials), "Other" (4 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "CP-690,550" (2 trials), "Efavirenz" (2 trials), "Golimumab" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chris Hani Baragwanath Hospital" are 39 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Chris Hani Baragwanath Hospital". 1 are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Chris Hani Baragwanath Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Chris Hani Baragwanath Hospital, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 5 trials that are defined as “Not Applicable".

Chris Hani Baragwanath Hospital has several departments that took part in Clinical trials: "Chris Hani Baragwanath Hospital, Department of Cardiology" - 2 trials